packageSotrovimab

sotrovimab

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Sotrovimab is a monoclonal antibody used to treat COVID-19. It has been approved and used against COVID-19, though its marketing authorisation in the European Union has been withdrawn.

Summary written by glm-5.3-flash from Wikidata Q106943333 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:sotrovimab
ATC codes:J06BD05
DrugBank:DB16355
Wikidata:Q106943333
molar mass:149000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown